Association of maternal serum high sensitive C-reactive protein level with body mass index and severity of pre-eclampsia at third trimester

Journal of Obstetrics and Gynaecology Research

Volumn 36, Issue 5, 2010, Pages 970-977

  Ertas, Ibrahim E ^a   Kahyaoglu, Serkan ^a   Yilmaz, Bulent ^a   Ozel, Murat ^a   Sut, Necdet ^b   Guven, Melih A ^c   Danisman, Nuri ^a  

^a ZEKAI TAHIR BURAK WOMEN S HEALTH EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c Anatolia Advanced Level Ultrasonography Center   (Turkey)

Author keywords

adverse outcomes; body mass index; C reactive protein; severe pre eclampsia

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HELLP SYNDROME; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; PREECLAMPSIA; THIRD TRIMESTER PREGNANCY;

ANALYSIS OF VARIANCE; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; PATIENT SELECTION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, THIRD; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 77957571278     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2010.01279.x     Document Type: Article

References (34)

1. Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med 1996 335 : 257 265.
2. Martin JN Jr., Rinehart BK, May WL, Magann EF, Terrone DA, Blake PG. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels and low platelet count) syndrome classification. Am J Obstet Gynecol 1999 180 : 1373 1384.
3. Liu CM, Chang SD, Cheng PJ, Chao AS. Comparisons of maternal and perinatal outcomes in Taiwanese women with complete and partial HELLP syndrome and women with severe pre-eclampsia without HELLP. J Obstet Gynaecol Res 2006 32 : 550 558.
4. Mei S, Gu H, Wang Q, Zhang S, Zeng Y. Pre-eclampsia outcomes in different hemodynamic models. J Obstet Gynaecol Res 2008 34 : 179 188.
5. Dissanayake VH, Samarasinghe HD, Morgan L, Jayasekara RW, Seneviratne HR, Pipkin FB. Morbidity and mortality associated with pre-eclampsia at two tertiary care hospitals in Sri Lanka. J Obstet Gynaecol Res 2007 33 : 56 62.
6. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999 180 : 499 506.
7. Kupferminc MJ, Peaceman AM, Aderka D, Wallach D, Socol ML. Soluble tumor necrosis factor and interleukin-6 levels in patients with severe preeclampsia. Obstet Gynecol 1996 88 : 420 427.
8. Conrad KP, Miles TM, Benyo DF. Circulating levels of immuno-reactive cytokines in women with preeclampsia. Am J Reprod Immunol 1998 40 : 102 111.
9. Savvidou MD, Lees CC, Parra M, Hingorani AD, Nicolaides KH. Levels of C-reactive protein in pregnant women who subsequently develop pre-eclampsia. Br J Obstet Gynaecol 2002 109 : 297 301.
10. Kumru S, Godekmerdan A, Kutlu S, Ozcan Z. Correlation of maternal serum high-sensitive C-reactive protein levels with biochemical and clinical parameters in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2006 124 : 164 167.
11. Kluft C, de Maat MP. Sensitive markers of inflammation make it possible to study the chronic process: the rise of interest in low levels of C-reactive protein. Vascul Pharmacol 2002 39 : 99 104.
12. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998 98 : 731 733.
13. Teran E, Escudero C, Moya W, Flores M, Vallance P, Lopez-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with preeclampsia. Int J Gynaecol Obstet 2001 75 : 243 249.
14. Belo L, Santos-Silva A, Caslake M et al. Neutrophil activation and C-reactive protein concentration in preeclampsia. Hypertens Pregnancy 2003 22 : 129 141.
15. Wolf MS, Kettyle EP, Sandler L, Ecker JL, Roberts J, Thadhani R. Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol 2001 98 : 757 762.
16. Visser M, Bouter LM, McQuillan GM, Wener MH, Haris TB. Elevated C-reactive protein levels in overweight and obese adults. J Am Med Assoc 1999 282 : 2131 2135.
17. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab 2003 88 : 3507 3512.
18. Picklesimer AH, Jared HL, Moss K, Offenbacher S, Beck JD, Boggess KA. Racial differences in C-reactive protein levels during normal pregnancy. Am J Obstet Gynecol 2008 199 : 523.
19. ACOG Committee on Practice Bulletins - Obstetrics. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002 99 : 159 167.
20. Lenfant C. National Education Program Working Group on High Blood Pressure in Pregnancy. Working group report on high blood pressure in pregnancy. J Clin Hypertens (Greenwich) 2001 3 : 75 88.
21. Ustun Y, Engin-Ustun Y, Kamaci M. Association of fibrinogen and C-reactive protein with severity of preeclampsia. Eur J Obstet Gynecol Reprod Biol 2005 121 : 154 158.
22. Sacks GP, Seyani L, Lavery S, Trew G. Maternal C-reactive protein levels are raised at 4 weeks of gestation. Hum Reprod 2004 19 : 1025 1030.
23. Tjoa ML, van Vugt JMG, Go AT, Blankenstein MA, Oudejans CBM, van Wijk IJ. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol 2003 59 : 29 37.
24. Hwang HS, Kwon JY, Kim MA, Park YW, Kim YH. Maternal serum highly sensitive C-reactive protein in normal pregnancy and pre-eclampsia. Int J Gynaecol Obstet 2007 98 : 105 109.
25. Deveci K, Sogut E, Evliyaoglu O, Duras N. Pregnancy-associated plasma protein-A and C-reactive protein levels in pre-eclamptic and normotensive pregnant women at third trimester. J Obstet Gynaecol Res 2009 35 : 94 98.
26. Qiu C, Luthy DA, Zhang C, Walsh SW, Leisenring WM, Williams MA. A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia. Am J Hypertens 2004 17 : 154 160. (Pubitemid 38125133)
27. Wolf MS, Kettyle EP, Ecker JL, Frigoletto FD, Thadhani RI. First trimester high resolution C-reactive protein and risk of hypertensive disorders of pregnancy. J Soc Gynecol Invest 2001 8 (Suppl 278A.
28. Djurovic S, Clausen T, Wergeland R, Brosstad F, Berg K, Henriksen T. Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent preeclampsia. Br J Obstet Gynaecol 2002 109 : 759 764.
29. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C-reactive protein and its relation to cardiovascular risk factors: a population based cross-sectional study. BMJ 1996 312 : 1061 1065.
30. Leeners B, Rath W, Kuse S, Irawan C, Imthurn B, Neumaier-Wagner P. BMI: new aspects of a classical risk factor for hypertensive disorders in pregnancy. Clin Sci (Lond) 2006 111 : 81 86.
31. Kilic-Okman T, Kucuk M, Ekuklu G. C-reactive protein and body mass index in women with pre-eclampsia. Int J Gynaecol Obstet 2004 84 : 75 76.
32. Karinen L, Leinonen M, Bloigu A et al. Maternal serum Chlamydia pneumoniae antibodies and CRP levels in women with preeclampsia and gestational hypertension. Hypertens Pregnancy 2008 27 : 143 158.
33. Teran E, Escudero C, Calle A. C-reactive protein during normal pregnancy and preeclampsia. Int J Gynaecol Obstet 2005 89 : 299 300.
34. Guven MA, Coskun A, Ertas IE, Aral M, Zencirci B, Oksuz H. Association of maternal serum CRP, IL-6, TNF-alpha, homocysteine, folic acid and vitamin B12 levels with the severity of preeclampsia and fetal birth weight. Hypertens Pregnancy 2009 28 : 190 200.